SCHEMBL2267166

SCHEMBL2267166

CC(=O)Oc1ccc2c(c1)OC(C)(C)O2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.48
MAPT P10636 4/20 0.48
ALDH1A1 P00352 3/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
USP2 O75604 1/20 0.48
HTT P42858 1/20 0.48
CA2 P00918 2/20 0.48
CA5A P35218 2/20 0.48
KDM4E B2RXH2 4/20 0.45
CA12 O43570 2/20 0.45
CA9 Q16790 2/20 0.45
GLA P06280 2/20 0.45
GAA P10253 2/20 0.45
POLB P06746 2/20 0.45
TDP1 Q9NUW8 1/20 0.45
TSHR P16473 1/20 0.45
CYP3A4 P08684 2/20 0.44
FLT3 P36888 1/20 0.44
ACHE P22303 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22396834 0.84 MRGPRX4 (0.49) LMNAMAPTALDH1A1MEN1KMT2A
SCHEMBL11001655 0.83 LMNA (0.44) LMNAMAPTALDH1A1MEN1KMT2A
SCHEMBL8282264 0.82 CA2 (0.40) LMNAMAPTALDH1A1MEN1KMT2A
SCHEMBL11002262 0.81 MAPT (0.48) LMNAMAPTALDH1A1MEN1KMT2A
SCHEMBL15092023 0.81 KMT2A (0.47) LMNAMAPTALDH1A1MEN1KMT2A
SCHEMBL23558705 0.81 ELANE (0.43) LMNAMAPTALDH1A1MEN1KMT2A
SCHEMBL11004782 0.79 MAPT (0.49) LMNAMAPTALDH1A1MEN1KMT2A
SCHEMBL11005433 0.79 LMNA (0.41) LMNAMAPTALDH1A1MEN1KMT2A
SCHEMBL23558706 0.78 ELANE (0.47) LMNAMAPTALDH1A1MEN1KMT2A
SCHEMBL23558707 0.78 KMT2A (0.36) LMNAMAPTALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9174979-B2 Phenanthroindolizidine compound and NFκB inhibitor containing same as active ingredient KABUSHIKI KAISHA YAKULT HONSHA (JP) 2015-11-03 US disclosed
EP-2351754-B1 PHENANTHROINDOLIZIDINE COMPOUND AND NF kB INHIBITOR CONTAINING SAME AS ACTIVE INGREDIENT YAKULT HONSHA KK (JP) 2015-06-24 EP disclosed
US-20110201638-A1 PHENANTHROINDOLIZIDINE COMPOUND AND NFkB INHIBITOR CONTAINING SAME AS ACTIVE INGREDIENT KABUSHIKI KAISHA YAKULT HONSHA (JP) 2011-08-18 US disclosed
EP-2351754-A1 PHENANTHROINDOLIZIDINE COMPOUND AND NF B INHIBITOR CONTAINING SAME AS ACTIVE INGREDIENT Kabushiki Kaisha Yakult Honsha (JP) 2011-08-03 EP disclosed
US-7585891-B2 5-(3,3-Dichloroprop-2-enyloxy)-2-[4-(2,2-dimethylbenzo[d]1,3-dioxolan-4-yloxy)butoxy]-1,3-dichlorobenzene; acaricides FMC CORPORATION (US) 2009-09-08 US disclosed
US-7585891-B2 5-(3,3-Dichloroprop-2-enyloxy)-2-[4-(2,2-dimethylbenzo[d]1,3-dioxolan-4-yloxy)butoxy]-1,3-dichlorobenzene; acaricides FMC CORPORATION (US) 2009-09-08 US disclosed
US-7585891-B2 5-(3,3-Dichloroprop-2-enyloxy)-2-[4-(2,2-dimethylbenzo[d]1,3-dioxolan-4-yloxy)butoxy]-1,3-dichlorobenzene; acaricides FMC CORPORATION (US) 2009-09-08 US disclosed
EP-1622889-A4 PESTICIDAL (DIHALOPROPENYL)PHENYLALKYL SUBSTITUTED BENZODIOXOLANE AND BENZODIOXOLE DERIVATIVES BAYER CROPSCIENCE AG (DE) 2008-01-16 EP disclosed
US-20060247283-A1 Pesticidal (dihalopropenyl)phenylalkyl substituted benzodioxolane and benzodioxole derivatives FMC CORPORATION 2006-11-02 US disclosed
EP-1622889-A2 PESTICIDAL (DIHALOPROPENYL)PHENYLALKYL SUBSTITUTED BENZODIOXOLANE AND BENZODIOXOLE DERIVATIVES FMC CORPORATION (US) 2006-02-08 EP disclosed
WO-2004098284-A2 PESTICIDAL (DIHALOPROPENYL)PHENYLALKYL SUBSTITUTED BENZODIOXOLANE AND BENZODIOXOLE DERIVATIVES FMC CORPORATION (US) 2004-11-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110201638-A1 PHENANTHROINDOLIZIDINE COMPOUND AND NFkB INHIBITOR CONTAINING SAME AS ACTIVE INGREDIENT NFKBIA, NFKB2, NFKB1 LMNA 1741/4885MAPT 3802/4885ALDH1A1 2881/4885
US-20060247283-A1 Pesticidal (dihalopropenyl)phenylalkyl substituted benzodioxolane and benzodioxole derivatives DDT, BBOX1, PDHX LMNA 2673/4885MAPT 4703/4885ALDH1A1 606/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.